Winton Group LTD Innoviva, Inc. Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $1.15 Million - $1.38 Million	-100,899 Reduced 81.78%	22,478 $286,000
Q1 2023 May 12, 2023	BUY	$10.73 - $13.6 $299,731 - $379,902	27,934 Added 29.27%	123,377 $1.39 Million
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $47,554 - $55,533	4,030 Added 4.41%	95,443 $1.26 Million
Q3 2022 Nov 10, 2022	SELL	$11.61 - $15.22 $2.08 Million - $2.73 Million	-179,393 Reduced 66.24%	91,413 $1.06 Million
Q2 2022 Aug 10, 2022	BUY	$14.32 - $19.88 $765,418 - $1.06 Million	53,451 Added 24.59%	270,806 $4 Million
Q1 2022 May 11, 2022	SELL	$15.39 - $20.25 $58,759 - $77,314	-3,818 Reduced 1.73%	217,355 $4.21 Million
Q4 2021 Feb 10, 2022	BUY	$15.91 - $18.72 $219,319 - $258,055	13,785 Added 6.65%	221,173 $3.82 Million
Q3 2021 Oct 28, 2021	BUY	$13.06 - $17.24 $33,198 - $43,824	2,542 Added 1.24%	207,388 $3.47 Million
Q2 2021 Aug 10, 2021	BUY	$11.45 - $13.96 $264,002 - $321,875	23,057 Added 12.68%	204,846 $2.75 Million
Q1 2021 Jul 21, 2021	BUY	$11.06 - $12.87 $141,203 - $164,311	12,767 Added 7.55%	181,789 $2.17 Million
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $2.59 Million - $3.46 Million	-277,582 Reduced 62.15%	169,022 $2.09 Million
Q3 2020 Oct 30, 2020	SELL	$10.33 - $14.49 $1.04 Million - $1.46 Million	-100,783 Reduced 18.41%	446,604 $4.67 Million
Q2 2020 Aug 05, 2020	SELL	$11.49 - $15.26 $1.52 Million - $2.01 Million	-131,992 Reduced 19.43%	547,387 $7.65 Million
Q1 2020 May 11, 2020	SELL	$8.11 - $15.23 $709,852 - $1.33 Million	-87,528 Reduced 11.41%	679,379 $7.99 Million
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $6.18 Million - $8.65 Million	601,415 Added 363.41%	766,907 $10.9 Million
Q3 2019 Nov 08, 2019	SELL	$10.05 - $14.55 $2.8 Million - $4.05 Million	-278,253 Reduced 62.71%	165,492 $1.74 Million
Q2 2019 Jul 08, 2019	SELL	$13.1 - $14.95 $4.65 Million - $5.3 Million	-354,636 Reduced 44.42%	443,745 $6.46 Million
Q1 2019 May 13, 2019	SELL	$13.69 - $20.06 $1.48 Million - $2.17 Million	-108,266 Reduced 11.94%	798,381 $11.2 Million
Q4 2018 Feb 05, 2019	BUY	$13.96 - $18.26 $4.77 Million - $6.25 Million	342,018 Added 60.57%	906,647 $15.8 Million
Q3 2018 Nov 02, 2018	BUY	$13.63 - $15.7 $7.7 Million - $8.86 Million	564,629 New	564,629 $0
Q2 2018 Aug 20, 2018	SELL	$13.44 - $17.59 $5.2 Million - $6.8 Million	-386,544 Closed	0 $0
Q1 2018 May 21, 2018	BUY	$13.8 - $16.99 $5.33 Million - $6.57 Million	386,544 New	386,544 $0

Others Institutions Holding INVA

# of Institutions

227

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

Black Rock Inc. New York, NY

9.63M
Shares

$172 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$130 Million
34.93% of portfolio
Franklin Resources Inc San Mateo, CA

6.75M
Shares

$120 Million
0.04% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$112 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.23M
Shares

$111 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account